Researcher
Philip Van Damme
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Behavioural neuroscience
- Disciplines (KU Leuven):Neurological and neuromuscular diseases
- See also: Philip Van Damme (Flanders Institute for Biotechnology)
Affiliations
- Van Den Bosch Lab (Research group)
Member
From1 Jan 2017 → Today - Laboratory for Neurobiology (VIB-KU Leuven) (Lab)
Member
From1 Jan 2012 → Today - Research Group Experimental Neurology (Division)
Member
From1 Oct 2000 → 31 Dec 2011
Projects
1 - 10 of 49
- Towards mechanistic biomarkers for amyotrophic lateral sclerosisFrom1 Jan 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Mapping the microglial heterogeneity in C9orf72-ALS and sporadic ALS using single cell profilingFrom1 Nov 2023 → TodayFunding: BOF - postdoctoral mandates
- A multi-modal and longitudinal approach to study the neurobiological underpinnings of disease onset and progression in genetic ALS variants: from presymptomatic to symptomatic disease stages.From1 Oct 2023 → TodayFunding: FWO junior postdoctoral fellowship
- HDAC6 inhibition restores TDP-43 pathology and axonal transport defects in human motor neurons with TARDBP mutationsFrom19 Apr 2023 → 31 Dec 2023Funding: Foundations, funds and other with scientific goal
- Measuring brain activation non-invasively in freely moving healthy and neuropsychiatric human populations using functional near-infrared spectroscopy (fNIRS)From1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Investigating the role of cilia dysfunction in Amyotrophic Lateral SclerosisFrom1 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Mechanisms of motor neuron degeneration in amyotrophic lateral sclerosis (ALS): cell death pathways and/or aberrant communication between cell body and neuromuscular junctionsFrom1 Oct 2022 → TodayFunding: BOF - projects
- A multi-modal approach to study C9orf72-mediated diseaseFrom16 May 2022 → 15 May 2023Funding: BOF - postdoctoral mandates
- Biomarkers in asymptomatic carriers of ALS-related mutationsFrom1 Apr 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Understanding lysosomal dysfunction in the frontotemporal dementiaamyotrophic lateral sclerosis spectrum of neurodegenerative disorders.From1 Jan 2022 → TodayFunding: FWO research project (including WEAVE projects)
Publications
211 - 220 of 341
- Prognostic value of clinical and electrodiagnostic parameters at time of diagnosis in patients with amyotrophic lateral sclerosis(2017)
Authors: Maarten Schrooten, Kristl Claeys, Wim Robberecht, Steffen Fieuws, Philip Van Damme
Pages: 341 - 350 - Screening for lipoprotein receptor-related protein 4-, agrin-, and titin-antibodies and exploring the autoimmune spectrum in myasthenia gravis(2017)
Authors: Philip Van Damme, Kristl Claeys
Pages: 1193 - 1203 - Metabolic syndrome, neurotoxic 1-deoxysphingolipids and nervous tissue inflammation in Chronic Idiopathic Axonal Polyneuropathy (CIAP)(2017)
Authors: Philip Van Damme, Kristl Claeys
- Brein & zorg(2017)
Authors: Philip Van Damme, Christophe Lafosse
- July 2017 ENCALS statement on edaravone(2017)
Authors: Philip Van Damme
Pages: 471 - 474 - Diagnostic Challenges and Clinical Characteristics of Hepatitis E Virus-Associated Guillain-Barré Syndrome(2017)
Authors: Kristl Claeys, Koen Poesen, Philip Van Damme
Pages: 26 - 33 - July 2017 ENCALS statement on edaravone(2017)
Authors: Ammar Al-Chalabi, Peter M Andersen, Siddharthan Chandran, Adriano Chio, Philippe Corcia, Philippe Couratier, Olof Danielsson, Mamede de Carvalho, Claude Desnuelle, Torsten Grehl, et al.
Pages: 471 - 474 - Sporadic late-onset nemaline myopathy: clinico-pathological characteristics and review of 76 cases(2017)
Authors: Philip Van Damme, Thomas Tousseyn, Dietmar Thal, Kristl Claeys
Pages: 86 - 98 - Anterior interosseous mononeuropathy associated with HEV infection(2017)
Authors: Bart Swinnen, Steven Boeynaems, Maarten Schrooten, Kristl Claeys, Philip Van Damme
- Positron emission tomography in amyotrophic lateral sclerosis: Towards targeting of molecular pathological hallmarks(2016)
Authors: Stefanie Willekens, Donatienne Van Weehaeghe, Philip Van Damme, Koen Van Laere
Pages: 533 - 547